Target intelligence / Profile preview

Transcription factor A, mitochondrial pseudogene 2 (TFAMP2)

Target
TFAMP2
Molecular classification
Pseudogene
01

Overview

Transcription factor A, mitochondrial pseudogene 2 (TFAMP2) is a processed pseudogene found in the human genome. It is homologous to the functional mitochondrial transcription factor gene (TFAM), but unlike TFAM, TFAMP2 does not encode a functional protein and does not perform biological roles in mitochondrial transcription or replication. The designation “MTTF1” is commonly used for functional TFAM, so applying it to TFAMP2 may cause confusion; thus, this pseudogene is not considered a valid drug target, nor does it have characterized biological activity or disease associations. Clarifications & Corrections: - The entry TFAMP2 is a pseudogene and not an active protein-coding gene or receptor. - Its aliases overlap with those of the real mitochondrial transcription factor (TFAM), causing ambiguity. In structured databases, MTTF1 usually refers to the active mitochondrial transcription factor, not the pseudogene. - There are multiple TFAM pseudogenes annotated in the human genome, but none of them are established therapeutic targets or have a protein product. - If you seek information on the functional mitochondrial transcription factor A (TFAM/MTTF1), see other entries; otherwise, for TFAMP2, it is correct to flag as a pseudogene entry. In summary: TFAMP2 (Transcription factor A, mitochondrial pseudogene 2) is a non-functional pseudogene, not a therapeutic target, and is often misidentified as MTTF1 (which refers to the functional mitochondrial transcription factor A). There is no evidence for a protein product, biological function, or drug relevance for TFAMP2.

Other names
MTTF1TCF6L3

Beyond the preview

Go deeper on Transcription factor A, mitochondrial pseudogene 2 (TFAMP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription factor A, mitochondrial pseudogene 2 (TFAMP2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call